Skip to main content

The 2002 Women’s Health Initiative Study (WHI): What Did It Prove or Disprove? Future Directions

  • Chapter
  • First Online:
Hormone Therapy
  • 1431 Accesses

Abstract

The WHI findings were seen as conclusive by some, were resisted by others, and for a third group, presented an opportunity to bring to the fore the use of transdermal routes of administering HT, which had been used more widely in Europe than in the United States, and which were showing many fewer of the negative effects, primarily because it is not metabolized in the liver, as is oral HT, and because of the use, in the patches, creams and gels, or primarily estradiol.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Machens K, Schmidt-Gollwitzer K. Issues to debate on the Women’s Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma? Hum Reprod. 2003;18(10):1992–9.

    Article  PubMed  CAS  Google Scholar 

  2. Kmietowicz Z. Articles disputing link between HRT and breast cancer are “ridiculous” [news]. BMJ. 2012;344:e513. doi:10.1136/bmj.e513.

    Article  PubMed  Google Scholar 

  3. Morris E, Currie H. The British Menopause Society: next steps 2011 [editorial]. Menopause Int. 2011;17:35–6.

    Article  PubMed  Google Scholar 

  4. North American Menopause Society. NAMS 2011 isoflavones report. The role of soy isoflavones in menopausal health: report of the North American Menopause society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause 2011;18(7):732–53.

    Google Scholar 

  5. Rice S, Whitehead SA. Phytoestrogens and breast cancer—promoters or protectors? Endocr Relat Cancer. 2006;13:995–1015.

    Article  PubMed  CAS  Google Scholar 

  6. Schwartz E, Holtorf K. Hormones in wellness and disease prevention: common practices, current state of the evidence, and questions for the future. Prim Care. 2008;35(4):669–705.

    Article  PubMed  Google Scholar 

  7. Notelovitz M. The clinical practice impact of the Women’s Health Initiative: political vs biological correctness [guest editorial]. Maturitas. 2003;44:3–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). The 2002 Women’s Health Initiative Study (WHI): What Did It Prove or Disprove? Future Directions. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics